InsiderClue
Insiders · Profile

ELMS STEVE

Director at ADMA BIOLOGICS · Director at Marker Therapeutics. Filing since 16 Mar 2021. CIK 0001250195

ADMA ADMA BIOLOGICS, INC. Director · 10 trades MRKR Marker Therapeutics, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ADMA ADMA BIOLOGICS, INC.
6 Mar 2026
Director
Bought
7,000
$107.73K
0.3%
ADMA ADMA BIOLOGICS, INC.
5 Mar 2026
Director
Bought
7,000
$109.69K
0.3%
ADMA ADMA BIOLOGICS, INC.
16 Jun 2025
Director
Sold at will
194,749
$3.94M
69.0%
ADMA ADMA BIOLOGICS, INC.
13 Jun 2025
Director
Sold at will
137,931
$2.87M
32.8%
ADMA ADMA BIOLOGICS, INC.
12 Jun 2025
Director
Sold at will
92,941
$2.02M
4.4%
MRKR Marker Therapeutics, Inc.
23 Dec 2024
Director
Bought
11,085
$35.47K
3.5%
ADMA ADMA BIOLOGICS, INC.
19 Mar 2024
Director
Sold at will
411,829
$2.50M
16.3%
ADMA ADMA BIOLOGICS, INC.
18 Mar 2024
Director
Sold at will
49,887
$299.82K
1.9%
ADMA ADMA BIOLOGICS, INC.
15 Mar 2024
Director
Sold at will
183,008
$1.10M
6.6%
ADMA ADMA BIOLOGICS, INC.
14 Mar 2024
Director
Sold at will
448,276
$2.71M
14.0%
ADMA ADMA BIOLOGICS, INC.
13 Mar 2024
Director
Sold at will
407,000
$2.53M
11.3%
MRKR Marker Therapeutics, Inc.
16 Mar 2021
Director
Bought
1,142,857
$2.00M
57.1%
12 decisions on file.